News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Archer-Daniels-Midland (ADM) is back in focus after its second quarter 2026 earnings beat and a higher full year outlook, with Ag Services & Oilseeds …
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup negative 35.7%Earnings Call Insights: ADMA Biologics (ADMA) Q2 2026 MANAGEMENT VIEW * Adam Grossman (Co-Founder, President, CEO & Director) framed Q2 as accelerating demand for the company’s higher-margin immunoglobulin product: “ASCENIV demand accelerated during the second quarter, and June delivered the strongest sequential utilization growth …
CHICAGO, August 05, 2026--(BUSINESS WIRE)--ADM's (NYSE: ADM) Board of Directors has declared a cash dividend of 52.0 cents per share on the company's common stock. The dividend is payable on Sept. 9, 2026, to shareholders of record on Aug. 19, 2026. This is ADM's …
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup negative 35.7%ADMA Biologics, Inc. reported its Q2 revenue at $124.4 million, which was slightly below the FactSet estimate of $125.3 million. The company, a biopharmaceutical firm specializing in plasma-derived biologics, is scheduled to hold its Q2 2026 Earnings Call on August 5, 2026. This earnings …
Archer-Daniels-Midland (NYSE: ADM) CFO Monish D. Patolawala had 6,720 shares of common stock withheld by the company on August 3, 2026. This action was taken to satisfy tax obligations related to the vesting of restricted stock unit awards. After this transaction, Patolawala directly owns …
ADMA Biologics reported strong second-quarter 2026 financial results, with total revenue reaching $124.4 million, up 2% year-over-year, driven primarily by ASCENIV sales which grew 24% to $102.9 million. The company reiterated its full-year 2026 financial guidance and highlighted new real-world data supporting ASCENIV's effectiveness …
Archer-Daniels-Midland Company announced it will maintain its quarterly dividend at $0.52 per share. This dividend is scheduled to be paid on September 9, 2026, to shareholders of record as of August 19, 2026. The announcement was made on August 5, 2026.
PHILADELPHIA, Aug. 05, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”) on behalf of investors who purchased or acquired ADMA common stock during the period from …
Archer-Daniels-Midland Company ADM used its second-quarter 2026 earnings call to frame the year around stronger biofuels economics and execution gains across crushing, ethanol and Nutrition. ADM raised its full-year outlook after adjusted earnings and revenue topped the Zacks Consensus Estimate. Management said second-half delivery …
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup negative 35.7%ADMA Biologics is set to report second-quarter earnings, with investors focused on whether the company can rebound from a disappointing prior quarter. Despite recent declines in analyst estimates, Wall Street remains optimistic with a mean price target of $17, implying significant upside. Key factors …
For those looking to find strong Consumer Staples stocks, it is prudent to search for companies in the group that are outperforming their peers. Archer Daniels Midland (ADM) is a stock that can certainly grab the attention of many investors, but do its recent …
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup negative 35.7%Archer-Daniels-Midland Company has filed a Form 424B2 preliminary prospectus supplement for an offering of an unspecified aggregate principal amount of notes due in 20XX, with interest payable semi-annually. The notes will be senior unsecured obligations and the proceeds will be used for general corporate …
This article details top Wall Street analyst upgrades, downgrades, and initiations for Wednesday, August 5, 2026, featuring companies like Archer-Daniels Midland, e.l.f. Beauty, Best Buy, and Dell Technologies. It also provides a market overview, noting the S&P 500's new all-time high, significant gains in …
Archer-Daniels-Midland (NYSE: ADM) reported strong second-quarter results, surpassing consensus estimates for adjusted earnings and revenue. Following these results, the company raised its full-year earnings outlook for fiscal 2026. Analysts from Morgan Stanley and Barclays subsequently increased their price targets for ADM.
Empowered Funds LLC significantly reduced its stake in Archer Daniels Midland Company (NYSE:ADM) by 51.4% in the first quarter, selling 44,500 shares. Despite this, other institutional investors have acquired new positions in ADM. The company reported strong Q2 earnings, beating analyst estimates with an …
Barclays has increased its price target for Archer-Daniels-Midland (ADM) to $90 from $85. This adjustment follows several other analyst revisions for ADM, including JPMorgan raising its target to $77 and BMO Capital to $82, while Morgan Stanley upgraded its rating to Equalweight with a …
Archer-Daniels-Midland Company Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Performance beat …
Sharemaestro market context Trend signal active 52 weeks +23.3% · Next-week setup negative 35.7%NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ: ADMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, …
This article first appeared on GuruFocus. Adjusted EPS: $1.84 for the second quarter of 2026. Total Segment Operating Profit: $1.5 billion for the second quarter of 2026. Adjusted ROIC: 7.8% on a trailing fourth quarter basis. Cash Flow from Operations (before working capital changes): …
Archer-Daniels-Midland (ADM) stock closed up 2.4% after reporting a strong rebound in quarterly profitability, with basic EPS at US$1.87 and net income at US$908m. Management also raised full-year adjusted earnings guidance, which significantly boosted investor confidence. The company's Q2 performance showed growth in Ag …
The Gross Law Firm is reminding investors of ADMA Biologics, Inc. (NASDAQ: ADMA) about an upcoming securities class action deadline of August 10, 2026. The lawsuit alleges that ADMA Biologics issued materially false and/or misleading statements, including engaging in an undisclosed related party transaction, …
Archer Daniels Midland (ADM) reported $22.68 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 7.2%. EPS of $1.84 for the same period compares to $0.93 a year ago. The reported revenue represents a surprise of +1.37% over the …
The Portnoy Law Firm has announced a class action lawsuit against ADMA Biologics, Inc. on behalf of investors who purchased securities between August 9, 2024, and March 25, 2026. The lawsuit alleges that ADMA Biologics and its executives made false and misleading statements by …
A securities fraud class action lawsuit has been filed against ADMA Biologics, Inc. and its executives following a 29% stock drop. The lawsuit alleges that ADMA engaged in a channel stuffing scheme to inflate revenue growth, purportedly driven by claims from Culper Research. Investors …
Archer-Daniels-Midland (ADM) reported robust Q2 2026 financial results, with adjusted earnings of $1.84 per share significantly exceeding analyst expectations of $1.46. The company posted revenue of $22.68 billion, a 7.2% increase year-over-year, driven by strong performance in its Ag Services and Oilseeds segment. Management …
Archer Daniels Midland (ADM) reported strong Q2 results, with earnings of $1.84 per share significantly beating the Zacks Consensus Estimate of $1.42 and last year's $0.93. The company's revenues also surpassed expectations, reaching $22.68 billion. With shares up 35.8% year-to-date and a Zacks Rank …
Archer-Daniels-Midland (ADM) stock surged by 4.1% in pre-market trading after reporting strong Q2 2026 financial results, which included a substantial earnings beat and a 7.2% year-on-year revenue increase to $22.68 billion. The company also significantly raised its 2026 adjusted earnings forecast, citing a positive …
Search by ticker symbol or company name and select a result to open its chart.